topotecan has been researched along with Argentaffinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansell, SM; Green, EM; Mahoney, MR; Rubin, J | 1 |
1 trial(s) available for topotecan and Argentaffinoma
| Article | Year |
|---|---|
Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Islet Cell; Carcinoma, Neuroendocrine; Female; Humans; Male; Middle Aged; Neutropenia; Survival Analysis; Topotecan | 2004 |